I am a
Home I AM A Search Login

Papers of the Week

2021 Apr 26

World J Clin Cases



Partial response to Chinese patent medicine Kangliu pill for adult glioblastoma: A case report and review of the literature.


Sun G, Zhuang W, Lin Q-T, Wang L-M, Zhen Y-H, Xi S-Y, Lin X-L
World J Clin Cases. 2021 Apr 26; 9(12):2845-2853.
PMID: 33969068.


Glioblastoma is the most common type of brain tumor and is invariably fatal, with a mean survival time of 8-15 mo for recently diagnosed tumors, and a 5-year survival rate of only 7.2%. The standard treatment for newly diagnosed glioblastoma includes surgery followed by concurrent chemoradiotherapy and further adjuvant temozolomide. However, the prognosis remains poor and long-term survival is rare. This report aimed to demonstrate a new therapeutic strategy for the treatment of glioblastoma.